The intestinal fatty acid binding protein diagnosing gut dysfunction in acute pancreatitis: A pilot study

Pancreas

Volumn 39, Issue 5, 2010, Pages 633-638

  Pan, Liya ^a   Wang, Xinying ^a   Li, Weiqin ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

citrulline; gut dysfunction score; intestinal fatty acid binding protein

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CITRULLINE; FATTY ACID BINDING PROTEIN 2; LACTULOSE; MANNITOL; FATTY ACID BINDING PROTEIN;

ACUTE PANCREATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENTERIC FEEDING; ENTEROPATHY; FEMALE; HUMAN; INTESTINE ABSORPTION; INTESTINE DYSFUNCTION; INTESTINE MUCOSA PERMEABILITY; LENGTH OF STAY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URINE LEVEL; AGED; BLOOD; COMPLICATION; INTESTINAL DISEASES; INTESTINE; MIDDLE AGED; PANCREATITIS; PATHOPHYSIOLOGY; PILOT STUDY; SEVERITY OF ILLNESS INDEX; URINE;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CITRULLINE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INTESTINAL DISEASES; INTESTINES; LACTULOSE; MALE; MANNITOL; MIDDLE AGED; PANCREATITIS; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX;

EID: 77954122847     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181c79654     Document Type: Article

References (40)

1. Hotz HG, Foitzik T, Rohweder J, et al. Intestinal microcirculation and gut permeability in acute pancreatitis: early changes and therapeutic implications. J Gastrointest Surg. 1998;2:518-525.
2. Nagpal K, Minocha VR, Agrawal V, et al. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg. 2006;192:24-28.
3. Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology. 1995;108:1566-1581.
4. Lima AA, Silva TM, Gifoni AM, et al. Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in Northeast Brazil. Am J Gastroenterol. 1997;92:1861-1866.
5. Gupta R, Wig JD, Bhasin DK, et al. Severe acute pancreatitis: the life after. J Gastrointest Surg. 2009;13:1328-1336.
6. Juvonen PO, Alhava EM, Takala JA. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol. 2000;35:1314-1318.
7. Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007;19:545-552.
8. Pelsers MM, Hermens WT, Glatz JF. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta. 2005;352: 15-35.
9. Gollin G, Marks C, Marks WH. Intestinal fatty acid binding protein in serum and urine reflects early ischemic injury to the small bowel. Surgery. 1993;113:545-551.
10. Sonnino R, Ereso G, Arcuni J, et al. Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemia. Transplant Proc. 2000;32:1280.
11. Wiercinska-Drapalo A, Jaroszewicz J, Siwak E, et al. Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis. Regul Pept. 2008;147: 25-28.
12. Derikx JP, Poeze M, van Bijnen AA, et al. Evidence for intestinal and liver epithelial cell injury in the early phase of sepsis. Shock. 2007;28:544-548.
13. Cronk DR, Houseworth TP, Cuadrado DG, et al. Intestinal fatty acid binding protein (I-FABP) for the detection of strangulated mechanical small bowel obstruction. Curr Surg. 2006;63:322-325.
14. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008;27:328-339.
15. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg. 1993;128:586-590.
16. Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care. 2008;12:R161.
17. McClave SA, Snider HL, Lowen CC, et al. Use of residual volume as a marker for enteral feeding intolerance: prospective blinded comparison with physical examination and radiographic findings. JPEN J Parenter Enteral Nutr. 1992;16:99-105.
18. Berger MM, Oddo M, Lavanchy J, et al. Gastrointestinal failure score in critically ill patients. Crit Care. 2008;12:436.
19. Reintam A, Parm P, Kitus R, et al. Gastrointestinal failure score in critically ill patients: a prospective observational study. Crit Care. 2008;12:R90.
20. Fangnan L, Li T, Nan L, et al. Determination of serum citrulline levels in normal Chinese people with HPLC. Panenter Enteral Nutri. 2004;11:116-117.
21. Crenn P, Coudray-Lucas C, Thuillier F, et al. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000;119: 1496-1505.
22. Santarpia L, Catanzano F, Ruoppolo M, et al. Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Ann Nutr Metab. 2008;53:137-142.
23. Liu H, Li W, Wang X, et al. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas. 2008;36:192-196.
24. Ammori BJ. Role of the gut in the course of severe acute pancreatitis. Pancreas. 2003;26:122-129.
25. Ammori BJ, Leeder PC, King RF, et al. Early increase in intestinal permeability in patients with severe acute pancreatitis: correlation with endotoxemia, organ failure, and mortality. J Gastrointest Surg. 1999;3:252-262.
26. Balzan S, de Almeida Quadros C, de Cleva R, et al. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol. 2007;22:464-471.
27. Marks WH, Gollin G. Biochemical detection of small intestinal allograft rejection by elevated circulating levels of serum intestinal fatty acid binding protein. Surgery. 1993;114:206-210.
28. Lieberman JM, Sacchettini J, Marks C, et al. Human intestinal fatty acid binding protein: report of an assay with studies in normal volunteers and intestinal ischemia. Surgery. 1997;121:335-342.
29. Holmes JHT, Lieberman JM, Probert CB, et al. Elevated intestinal fatty acid binding protein and gastrointestinal complications following cardiopulmonary bypass: a preliminary analysis. J Surg Res. 2001; 100:192-196.
30. Kaufman SS, Lyden ER, Marks WH, et al. Lack of utility of intestinal fatty acid binding protein levels in predicting intestinal allograft rejection. Transplantation. 2001;71:1058-1060.
31. Rahman SH, Ammori BJ, Holmfield J, et al. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis. J Gastrointest Surg. 2003;7:26-35; discussion 35-36.
32. Fink MP, Antonsson JB, Wang HL, et al. Increased intestinal permeability in endotoxic pigs. Mesenteric hypoperfusion as an etiologic factor. Arch Surg. 1991;126:211-218.
33. Flint R, Windsor J. The role of the intestine in the pathophysiology and management of severe acute pancreatitis. HPB (Oxford). 2003;5:69-85.
34. De Campos T, Cerqueira C, Kuryura L, et al. Morbimortality indicators in severe acute pancreatitis. JOP. 2008;9:690-697.
35. Hagiwara A, Miyauchi H, Shimazaki S. Predictors of vascular and gastrointestinal complications in severe acute pancreatitis. Pancreatology. 2008;8:211-218.
36. Fiddian-Green RG. Associations between intramucosal acidosis in the gut and organ failure. Crit Care Med. 1993;21: S103-S107.
37. Illig KA, Ryan CK, Hardy DJ, et al. Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue. Surgery. 1992;112:631-637.
38. Eckerwall GE, Axelsson JB, Andersson RG. Early nasogastric feeding in predicted severe acute pancreatitis: a clinical, randomized study. Ann Surg. 2006;244:959-965.
39. Doley RP, Yadav TD, Wig JD, et al. Enteral nutrition in severe acute pancreatitis. JOP. 2009;10:157-162.
40. Mora J, Casas M, Cardona D, et al. Effect of enteral versus parenteral nutrition on inflammatory markers in severe acute pancreatitis. Pancreas. 2007;35:292.